Compassionate Use Nordic in Qatar
How the compassionate use nordic pathway operates in Qatar.
About Compassionate Use Nordic
Denmark / Sweden / Norway / Finland compassionate-use frameworks.
How Compassionate Use Nordic works in Qatar
Qatar's MoPH permits unregistered drug import under a named-patient pathway with physician and MoPH approval; Hamad Medical Corp frequently sponsors.
Patients in Qatar seeking access under Compassionate Use Nordic typically follow this flow: a licensed physician in Qatar issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Qatar
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.